Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis

Abstract

The worldwide endeavour to develop safe and effective COVID-19 vaccines has been extraordinary, and vaccination is now underway in many countries. However, the doses available in 2021 are likely to be limited. We extended a mathematical model of SARS-CoV-2 transmission across different country settings to evaluate the public health impact of potential vaccines using WHO-developed target product profiles. We identified optimal vaccine allocation strategies within- and between-countries to maximise averted deaths under constraints on dose supply. We found that the health impact of SARS-CoV-2 vaccination depends on the cumulative population-level infection incidence when vaccination begins, the duration of natural immunity, the trajectory of the epidemic prior to vaccination, and the level of healthcare available to effectively treat those with disease. Within a country we find that for a limited supply (doses for <20% of the population) the optimal strategy is to target the elderly. However, with a larger supply, if vaccination can occur while other interventions are maintained, the optimal strategy switches to targeting key transmitters to indirectly protect the vulnerable. As supply increases, vaccines that reduce or block infection have a greater impact than those that prevent disease alone due to the indirect protection provided to high-risk groups. Given a 2 billion global dose supply in 2021, we find that a strategy in which doses are allocated to countries proportional to population size is close to optimal in averting deaths and aligns with the ethical principles agreed in pandemic preparedness planning.HighlightsThe global dose supply of COVID-19 vaccines will be constrained in 2021Within a country, prioritising doses to protect those at highest mortality risk is efficientFor a 2 billion dose supply in 2021, allocating to countries according to population size is efficient and equitable

COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea

“…The UK government Vaccine Task Force decided to prioritize vaccination to senior citizens (over 50 years old), to those with comorbidities, and to the HCWs and front-line social workers of the COVID-19 response [ 7 ]. Moreover, the reduction of mortality was expected to be the highest when vaccination started at the older ages and expanded to younger ages, especially in developed countries [ 8 ].…”

COVID-19 Vaccine Perception in South Korea: Web Crawling Approach

“…Furthermore, the global economic loss due to COVID-19 in 2020 was estimated at US $9trillion [ 2 ]. Accordingly, the US Centers for Disease Control and Prevention (CDC) and the WHO determined that physical (social) distancing alone was insufficient to prevent and eliminate COVID-19 and stressed the need for vaccination while simultaneously initiating the development of COVID-19 vaccines [ 3 , 4 ].…”

How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks

“…For high vaccine efficacy, and when sufficiently many are vaccinated, it is optimal to vaccinate the younger age groups which account for the most transmissions. Similarly, Hogan et al [30] consider optimal age-targeted vaccination where the entire age group is assumed to be vaccinated at a constant rate over the course of one month. Acuna-Zegarra et al [31] use optimal control to conclude that intense vaccination for a limited time period is optimal.…”